Article

Clinical Q&A

Barbara Holmes Gobel

hypersensitivity
CJON 2002, 6(3), 177-180. DOI: 10.1188/02.CJON.177-180

We have observed an increase in the incidence of paclitaxel-related hypersensitivity reactions at our institution. Does any new information explain the etiology of these reactions? Should we change our standards for monitoring patients receiving paclitaxel infusions (e.g., begin placing patients on cardiac monitors)?

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.